Most Read Articles
Stephen Padilla, 3 days ago
Treatment with oral thrombopoietin receptor agonist eltrombopag leads to similar platelet counts in patients with chronic immune thrombocytopaenia (cITP) and persistent (per)ITP, according to the results of phase III (EXTEND) and IV studies presented at the 23rd Congress of the European Hematology Association (EHA 2018) held in Stockholm, Sweden.
4 days ago
Socioeconomic status, along with other social determinants, appears to influence the long-term outcomes in Asian acute heart failure patients, according to a recent Japan study.
Pearl Toh, 6 days ago
Lonely people were twice as likely to die from any cause than people who did not feel lonely, according to a study based on a national survey presented at the recent EuroHeartCare 2018 in Dublin, Ireland. Also, loneliness is associated with poorer patient-reported outcomes in terms of mental and physical health in patients with heart disease.
Jairia Dela Cruz, 3 days ago
A treatment regimen combining daratumumab plus bortezomib, melphalan and prednisone markedly extends progression-free survival in patients with multiple myeloma, inducing deep responses and demonstrating acceptable tolerability regardless of baseline renal function, according to the results of the phase III ALCYONE study.

NSAIDs do not improve mortality in preterm infants with patent ductus arteriosus

Audrey Abella
31 Jan 2017

Nonsteroidal anti-inflammatory drug (NSAID) treatment for patent ductus arteriosus (PDA) in preterm infants did not reduce the odds of mortality or bronchopulmonary dysplasia (BPD), a recent US study found.

Instrumental variable analysis did not reveal any association between NSAID treatment and the odds of mortality or BPD (odds ratio [OR], 0.94, 95 percent CI, 0.70–1.25; p=0.69), mortality (OR, 0.73, 95 percent CI, 0.43–1.13; p=0.18), or BPD (OR, 1.01, 95 percent CI, 0.73–1.45; p=0.94). [JAMA Pediatr 2017;doi:10.1001/jamapediatrics.2016.4354]

Researchers gathered data on 12,018 infants born at 28 gestational weeks or younger from the PHIS* database (Children’s Hospital Association, Shawnee Mission, Kansas, US).

Of these, 32 percent received NSAID treatment for PDA (7 percent on ibuprofen, 27 percent on indomethacin). The infants either received an initial dose of ibuprofen or indomethacin within the initial 28 postnatal days (4 or more days). Infants who received a prophylactic indomethacin dose to prevent intraventricular haemorrhage (daily dose from birth date for 3 consecutive days) were also qualified. Infants who received NSAID doses beyond 28 postnatal days were excluded.

PDA is present in infants at birth between 25 and 28 weeks gestation and is predominant in extremely preterm infants, with 35 percent closing within 1 week. However, nonclosure is associated with increased mortality and worsened respiratory outcomes including BPD. [Semin Perinatol 2012;36:123-129; Pediatrics 2009;123:e138-e144]

Although previous studies have demonstrated the efficacy of NSAIDs in PDA treatment, their ability to improve mortality or prevent BPD remain unclear. [Cochrane Database Syst Rev (2): CD003745, 2003; Cochrane Database Syst Rev (2):CD003481, 2015; Arch Dis Child Fetal Neonatal Ed 2007;92:F498-F502]

“Our findings … support a conservative approach to PDA management … Although NSAID treatment of all infants with PDA does not appear beneficial, our findings do not imply that some infants with certain risk factors may not benefit from PDA closure,” said the researchers.

 

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Stephen Padilla, 3 days ago
Treatment with oral thrombopoietin receptor agonist eltrombopag leads to similar platelet counts in patients with chronic immune thrombocytopaenia (cITP) and persistent (per)ITP, according to the results of phase III (EXTEND) and IV studies presented at the 23rd Congress of the European Hematology Association (EHA 2018) held in Stockholm, Sweden.
4 days ago
Socioeconomic status, along with other social determinants, appears to influence the long-term outcomes in Asian acute heart failure patients, according to a recent Japan study.
Pearl Toh, 6 days ago
Lonely people were twice as likely to die from any cause than people who did not feel lonely, according to a study based on a national survey presented at the recent EuroHeartCare 2018 in Dublin, Ireland. Also, loneliness is associated with poorer patient-reported outcomes in terms of mental and physical health in patients with heart disease.
Jairia Dela Cruz, 3 days ago
A treatment regimen combining daratumumab plus bortezomib, melphalan and prednisone markedly extends progression-free survival in patients with multiple myeloma, inducing deep responses and demonstrating acceptable tolerability regardless of baseline renal function, according to the results of the phase III ALCYONE study.